S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Strange change at your bank (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Strange change at your bank (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Strange change at your bank (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Strange change at your bank (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Strange change at your bank (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Strange change at your bank (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Strange change at your bank (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Strange change at your bank (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi

Lixte Biotechnology (LIXT) Institutional Ownership

$2.22
-0.15 (-6.33%)
(As of 02/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)

Current
Institutional Ownership
Percentage
11.85%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$642,199.90
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$531,054.70
Get LIXT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LIXT Institutional Buying and Selling by Quarter


Lixte Biotechnology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023Geode Capital Management LLC10,119$59K0.0%-90.0%0.606%
6/5/2023EP Wealth Advisors LLC2,211$0.79M0.0%N/A0.013%
5/16/2023Geode Capital Management LLC101,209$84K0.0%+292.4%0.608%
2/9/2023Ethos Financial Group LLC248,084$0.13M0.0%N/A1.490%
11/14/2022Renaissance Technologies LLC90,664$51K0.0%+58.5%0.545%
8/13/2022Renaissance Technologies LLC57,189$43K0.0%N/A0.344%
8/12/2022Almanack Investment Partners LLC.248,084$0.19M0.0%-66.7%1.490%
5/20/2022EP Wealth Advisors LLC25,025$31K0.0%N/A0.150%
11/9/2021BlackRock Inc.13,425$28K0.0%+191.9%0.098%
11/4/2021Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863%
8/16/2021State Street Corp33,600$0.10M0.0%N/A0.244%
8/16/2021Sabby Management LLC65,511$0.20M0.0%-17.8%0.477%
8/13/2021Renaissance Technologies LLC50,900$0.15M0.0%N/A0.370%
8/13/2021Vanguard Group Inc.74,383$0.23M0.0%N/A0.544%
8/4/2021Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189%
5/21/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174%
5/18/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174%
5/11/2021Almanack Investment Partners LLC.1,042,105$3.43M0.3%N/A7.698%
2/16/2021Santa Monica Partners LP166,667$0.53M0.4%N/A1.347%
(Data available from 1/1/2016 forward)













LIXT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LIXT shares?

During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: EP Wealth Advisors LLC ($0.79M), Almanack Investment Partners LLC. ($0.19M), Ethos Financial Group LLC ($0.13M), and Geode Capital Management LLC ($59K), Renaissance Technologies LLC ($51K).Learn more on LIXT's institutional investors.

What percentage of Lixte Biotechnology stock is owned by institutional investors?

11.85% of Lixte Biotechnology stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings.

Which institutional investors have been buying Lixte Biotechnology stock?

The following institutional investors have purchased Lixte Biotechnology stock in the last 24 months: Ethos Financial Group LLC ($0.25M), Renaissance Technologies LLC ($90.66K), Geode Capital Management LLC ($75.42K), and EP Wealth Advisors LLC ($27.24K).

How much institutional buying is happening at Lixte Biotechnology?

Institutional investors have bought a total of 441,399 shares in the last 24 months. This purchase volume represents approximately $2.83M in transactions.

Which Lixte Biotechnology major shareholders have been selling company stock?

The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: Almanack Investment Partners LLC. ($0.50M), and Geode Capital Management LLC ($91.09K).

How much institutional selling is happening at Lixte Biotechnology?

Institutional investors have sold a total of 587,090 shares in the last 24 months. This volume of shares sold represents approximately $4.22M in transactions.


This page (NASDAQ:LIXT) was last updated on 2/25/2024 by MarketBeat.com Staff